Eterna Therapeutics CMO Dr. Roger Sidhu resigns effective Jan 31, 2023

Ernexa Therapeutics Inc.

Dr. Roger Sidhu, Chief Medical Officer, resigned on Jan 20, 2023 with effective date Jan 31, 2023.
No replacement or interim CMO has been announced in the filing.
Departure is effective immediately at the end of January 2023.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Roger Sidhu

Chief Medical Officer

ERNA · Ernexa Therapeutics Inc.

Effective: 2023-01-31
Filed: January 26, 2023, 6:59 PM ET

On January 20, 2023, Dr. Roger Sidhu, Chief Medical Officer of Eterna Therapeutics Inc., a Delaware corporation, delivered his notice of resignation, with such resignation becoming effective on January 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Roger Sidhu resigned as Chief Medical Officer at Ernexa Therapeutics Inc..

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On January 20, 2023, Dr. Roger Sidhu, Chief Medical Officer of Eterna Therapeutics Inc., a Delaware corporation, delivered his notice of resignation, with such resignation becoming effective on January 31, 2023.

View on SEC.gov

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-002909

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.